Incyte, a global biopharmaceutical company based in Wilmington, Delaware, is a company founded on the premise that investment in good science and the rigorous pursuit of R&D excellence can translate into new medicines that can positively affect patients’ lives. Our therapeutic focus is primarily oncology. We believe the future of cancer treatment lies with immune therapies, which seek to recruit the patient’s own immune system to tackle cancer, and with targeted therapies, which aim to block the effects of cancer-causing mutations.
1801 Augustine Cut-off
Wilmington, Delaware 19803